Thus, our primary aim was to investigate whether the level of Lp-PLA2 was associated with subclinical atherosclerosis at baseline (T0) or after the first five years following a diagnosis of RA (T5). The gene discussed is PLA2G7; the disease is rheumatoid arthritis.